NCT07141329Phase 2Enrolling by invitation

SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures

Study sponsor: Supernus Pharmaceuticals, Inc. · SUPN

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-12-31Estimated
Enrollment · participants100Estimated
Source updated2026-10-27Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Recruiting. After: Enrolling by invitation.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview